Publicaciones en colaboración con investigadores/as de Montreal Heart Institute (6)

2019

  1. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study

    Journal of the American College of Cardiology, Vol. 73, Núm. 6, pp. 629-638

2010

  1. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial

    The Lancet, Vol. 376, Núm. 9748, pp. 1233-1243

2009

  1. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial

    JACC: Cardiovascular Interventions, Vol. 2, Núm. 11, pp. 1083-1091

2008

  1. Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the STEEPLE trial

    European Heart Journal, Vol. 29, Núm. 4, pp. 462-471

2006

  1. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

    New England Journal of Medicine, Vol. 355, Núm. 10, pp. 1006-1017

1997

  1. First international new intravascular rigid-flex endovascular stent study (FINESS): Clinical and angiographic results after elective and urgent stent implantation

    Journal of the American College of Cardiology, Vol. 30, Núm. 4, pp. 847-854